# US 2026/0132423 A1 · Method for Editing Bovine Gene Based on Pro-iCHI

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0132423 A1
- Document ID: US20260132423A1
- Status: Published application
- Kind: A1
- Application number: 19/275,963
- Filed: 2025-07-21
- Published: 2026-05-14
- Earliest claimed: 2024-11-14
- Assignees: Inner Mongolia University
- Applicants: Inner Mongolia University
- Inventors: Lei YANG; Anqi DI; Lishuang SONG; Xuefei LIU; Di WU; Song WANG; Zhenting HAO; Lige BU; Chunling BAI; Guanghua SU; Zhuying WEI; Li ZHANG; Zhonghua LIU; Shaorong GAO; Guangpeng LI
- Web page: https://patentgrep.com/patent/US20260132423A1

## CPC

- C12N 15/873: Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- A61D 19/04: for embryo transplantation
- C12N 5/0604: {Whole embryos; Culture medium therefor}
- C12N 9/1276: {RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/907: {in mammalian cells}
- C12Y 207/07049: RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
- A01K 2267/02: Animal zootechnically ameliorated
- C07K 2319/00: Fusion polypeptide
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2501/727: Kinases (EC 2.7.)
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61D: VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- C12Y: ENZYMES
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention belongs to the field of molecular biology and genetics, and in particular relates to a method for editing a bovine gene based on Pro-iCHI. The present invention provides a method for editing a bovine gene based on Pro-iCHI. Protamine is transiently expressed in gene-edited b-haSCs, which are then injected to mature oocytes to obtain reconstructed embryos. Protamine can eliminate abnormal DNA methylation resulting from oocyte intracytoplasmic haSCs injection and enable the nucli to compress into sperm-like structures, and the obtained bovine Pro-iCHI embryos can successfully develop into blastocysts, with a blastocyst rate comparable to that of the embryos obtained by in vitro fertilization. Moreover, in the present invention, a protamine-encoding gene is inserted into a Saccharomyces cerevisiae protein expression vector for transient expression, which ensures that abnormal DNA methylation is erased, without integration into the genome resulting in the insertion of exogenous genes.

## Claims

### Claim 1

A method for editing a bovine gene based on Pro-iCHI, comprising the following steps:
performing gene editing on bovine androgenetic haploid embryonic stem cells to obtain gene-edited b-haSCs;
transiently expressing protamine in the gene-edited b-haSCs to obtain gene-edited Pro-b-haSCs;
injecting the gene-edited Pro-b-haSCs into mature oocytes to obtain reconstructed embryos;
activating the reconstructed embryos with ionomycin, and then incubating a resulting reconstructed embryos with 6-dimethylaminopurine to obtain bovine Pro-iCHI embryos.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the transiently expressing protamine in the gene-edited b-haSCs is conducted as follows: transfecting the gene-edited b-haSCs with a recombinant vector;
the recombinant vector comprises a Saccharomyces cerevisiae protein expression vector and a protamine-encoding gene inserted into the Saccharomyces cerevisiae protein expression vector.

### Claim 3 (depends on 2)

The method according to claim 2, wherein a mode for the transfection comprises electro transfection.

### Claim 4 (depends on 1)

The method according to claim 1, wherein a concentration of the ionomycin is 5 μM to 10 μM; and the activating is conducted for 5 min to 10 min.

### Claim 5 (depends on 1)

The method according to claim 1, wherein a concentration of the 6-dimethylaminopurine is 2 mM to 4 mM; and the incubating is conducted for 5 h to 6 h.

### Claim 6 (depends on 1)

The method according to claim 1, wherein a mode for the performing gene editing on bovine androgenetic haploid embryonic stem cells comprises introducing a gene editing system into bovine androgenetic haploid embryonic stem cells;
the gene editing system comprises a base vector, and a prime editor and a fusion protein introduced into the base vector; the prime editor comprises a guide RNA, a primer sequence, and a transcription template sequence for a to-be-edited gene; and the guide RNA comprises a spacer sequence for the to-be-edited gene;
the fusion protein comprises a Cas9 protein in an H840A-nicked form and reverse transcriptase.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the gene editing is performed on an MSTN gene of bovine haploid androgenetic stem cells.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the nucleotide sequence of a spacer sequence used to locate the MSTN gene is set forth in SEQ ID NO: 4.

### Claim 9 (depends on 1)

A method for preparing gene-edited cattle, comprising culturing the obtained bovine Pro-iCHI embryos in claim 1, obtaining gene-edited blastocysts, and then performing embryo transplantation to obtain gene-edited cattle.

### Claim 10 (depends on 7)

The method according to claim 7, wherein the transiently expressing protamine in the gene-edited b-haSCs is conducted as follows: transfecting the gene-edited b-haSCs with a recombinant vector;
the recombinant vector comprises a Saccharomyces cerevisiae protein expression vector and a protamine-encoding gene inserted into the Saccharomyces cerevisiae protein expression vector.

### Claim 11 (depends on 7)

The method according to claim 7, wherein a mode for the transfection comprises electro transfection.

### Claim 12 (depends on 7)

The method according to claim 7, wherein a concentration of the ionomycin is 5 μM to 10 μM; and the activating is conducted for 5 min to 10 min.

### Claim 13 (depends on 7)

The method according to claim 7, wherein a concentration of the 6-dimethylaminopurine is 2 mM to 4 mM; and the incubating is conducted for 5 h to 6 h.

### Claim 14 (depends on 7)

The method according to claim 7, wherein a mode for the performing gene editing on bovine androgenetic haploid embryonic stem cells comprises introducing a gene editing system into bovine androgenetic haploid embryonic stem cells;
the gene editing system comprises a base vector, and a prime editor and a fusion protein introduced into the base vector; the prime editor comprises a guide RNA, a primer sequence, and a transcription template sequence for a to-be-edited gene; and the guide RNA comprises a spacer sequence for the to-be-edited gene;
the fusion protein comprises a Cas9 protein in an H840A-nicked form and reverse transcriptase.
